BELLVIRAX Tablets 200 mg Milligram
Negara: Irlandia
Bahasa: Inggris
Sumber: HPRA (Health Products Regulatory Authority)
Karakteristik produk
(SPC)
07-05-2024
Beberapa dokumen untuk produk ini saat ini tidak tersedia, Anda dapat mengirim permintaan ke layanan pelanggan kami dan kami akan memberi tahu Anda segera setelah kami bisa mendapatkannya.
Kirim permintaan.
Kirim permintaan.
Bahan aktif:
ACICLOVIR
Tersedia dari:
Ranbaxy Ireland Limited
Dosis:
200 mg Milligram
Bentuk farmasi:
Tablets
Tanggal Otorisasi:
1999-05-27
Karakteristik produk
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Bellvirax 200mg Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 200 mg tablet contains 200 mg aciclovir.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablets.
Capsule shaped, biconvex, uncoated white to off-white tablets with ‘200’ embossed on one side and ‘ACV’ on the
other side.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Bellvirax Tablets are indicated for the following:
treatment of herpes simplex virus infections involving the skin and mucous membranes, including initial and
recurrent genital herpes,
suppression of recurrence of herpes simplex virus infections in immunocompetent patients,
prophylaxis against herpes simplex virus infections in immunocompromised individuals,
treatment of herpes zoster (shingles) and varicella (chicken pox) infections.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Bellvirax Tablets should be dissolved in 100 ml (a glassful) of water immediately before taking, or swallowed
whole with water, according to the following dosage schedules:
Adults:
TREATMENT OF HERPES SIMPLEX VIRUS INFECTIONS:
200 mg, five times a day at four-hourly intervals, omitting the night time dose. Treatment is usually for 5 days, but
can be extended, depending on the severity of the infection.
In patients who are severely immunocompromised or with malabsorption, the dose may be increased to 400 mg.
Treatment should be started as soon as infection is evident; i.e. when lesions first appear, or for recurrent infections,
during the prodromal phase.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 21/02/2012_
_CRN 2109649_
_page number: 1_
SUPPRESSION OF RECURRENT HERPES SIMPLEX INFECTIONS IN
Baca dokumen lengkapnya
